RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES,

Category : Angiotensin receptor blocker. Mechanism of action: It acts specifically as a competative antagonist at the AT1 receptor. Even angiotensin receptor blocker can be increase in bradykinin due to AT2. Unlike saralasin it lacks any intrinsic agonist property. Given orally it is well absorbed and undergoes first pass metabolism in liver.(3) ................
................